Your browser doesn't support javascript.
loading
Recurrent DDX41 mutation in very late relapse after allogeneic stem cell transplantation.
Kambara, Yasuhiro; Sadato, Daichi; Toya, Takashi; Honda, Akira; Kato, Seiko; Hirama, Chizuko; Haraguchi, Kyoko; Shimizu, Hiroaki; Najima, Yuho; Kobayashi, Takeshi; Okuyama, Yoshiki; Harada, Hironori; Takahashi, Satoshi; Kurokawa, Mineo; Harada, Yuka; Doki, Noriko.
Affiliation
  • Kambara Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Sadato D; Clinical Research Support Center, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Toya T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan. tooya-tky@umin.ac.jp.
  • Honda A; Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Kato S; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Hirama C; Clinical Research Support Center, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Haraguchi K; Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Shimizu H; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Najima Y; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Kobayashi T; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Okuyama Y; Division of Transfusion and Cell Therapy, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Harada H; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Takahashi S; Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
  • Kurokawa M; Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Harada Y; Division of Clinical Precision Research Platform, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Doki N; Department of Hematology and Oncology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Leukemia ; 38(3): 667-670, 2024 03.
Article in En | MEDLINE | ID: mdl-38238444
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation Limits: Humans Language: En Year: 2024 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation Limits: Humans Language: En Year: 2024 Type: Article